The role of exosomal long non-coding RNAs in cancer drug resistance

Abstract

One of the major challenges in oncology is drug resistance, which triggers relapse and shortens patients’ survival. In order to promote drug desensitization, cancer cells require the establishment of an ideal tumor microenvironment that accomplishes specific conditions. To achieve this objective, cellular communication is a key factor. Classically, cells were believed to restrictively communicate by ligand-receptor binding, physical cell-to-cell interactions and synapses. Nevertheless, the crosstalk between tumor cells and stroma cells has also been recently reported to be mediated through exosomes, the smallest extracellular vesicles, which transport a plethora of functionally active molecules, such as: proteins, lipids, messenger RNA, DNA, microRNA or long non-coding RNA (lncRNAs). LncRNAs are RNA molecules greater than 200 base pairs that are deregulated in cancer and other diseases. Exosomal lncRNAs are highly stable and can be found in several body fluids, being considered potential biomarkers for tumor liquid biopsy. Exosomal lncRNAs promote angiogenesis, cell proliferation and drug resistance. The role of exosomal lncRNAs in drug resistance affects the main treatment strategies in oncology: chemotherapy, targeted therapy, hormone therapy and immunotherapy. Overall, knowing the molecular mechanisms by which exosomal lncRNA induce pharmacologic resistance could improve further drug development and identify drug resistance biomarkers.

Keywords

Tumor microenvironment / extracellular vesicles / exosomes / non-coding RNA / long non-coding RNA / drug resistance

References

[1] Siegel RL,Jemal A.Cancer statistics, 2019..CA Cancer J Clin2019;69:7-34

[2] Bray F,Soerjomataram I,Torre LA.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries..CA Cancer J Clin2018;68:394-424

[3] Calin GA,Shimizu M,Yendamuri S.Familial cancer associated with a polymorphism in ARLTS1..N Engl J Med2005;352:1667-76

[4] Zhou Y,Spizzo R,Mathur R.miR-203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinase..Mol Oncol2014;8:83-92 PMCID:PMC4124530

[5] Garcia-Mayea Y,Masson F,LLeonart ME.Insights into new mechanisms and models of cancer stem cell multidrug resistance..Semin Cancer Biol2019;

[6] Hanahan D.The hallmarks of cancer..Cell2000;100:57-70

[7] Hanahan D.Hallmarks of cancer: the next generation..Cell2011;144:646-74

[8] Bahrami A,Khazaei M,Shahidsales S.The therapeutic potential of targeting tumor microenvironment in breast cancer: rational strategies and recent progress..J Cell Biochem2018;119:111-22

[9] Soysal SD,Muenst SE.Role of the tumor microenvironment in breast cancer..Pathobiology2015;82:142-52

[10] Jin L,Marcusson EG,Calin GA.Prooncogenic factors miR-23b and miR-27b are regulated by Her2/Neu, EGF, and TNF-α in breast cancer..Cancer Res2013;73:2884-96 PMCID:PMC3855090

[11] Hu M,Cai L,van den Brûle F.Distinct epigenetic changes in the stromal cells of breast cancers..Nat Genet2005;37:899-905

[12] Obenauf AC,Ji AL,Shu W.Therapy-induced tumour secretomes promote resistance and tumour progression..Nature2015;520:368-72 PMCID:PMC4507807

[13] Easwaran H,Baylin SB.Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance..Mol Cell2014;54:716-27 PMCID:PMC4103691

[14] Fabbri M.Epigenetics and miRNAs in human cancer..Adv Genet2010;70:87-99

[15] Mittal S,Holen I.The breast tumor microenvironment: role in cancer development, progression and response to therapy..Expert Rev Mol Diagn2018;18:227-43

[16] Müller A,Soto H,Catron D.Involvement of chemokine receptors in breast cancer metastasis..Nature2001;410:50-6

[17] Dragomir M,Calin GA.Exosomal lncRNAs as new players in cell-to-cell communication..Transl Cancer Res2018;7:S243-52 PMCID:PMC6107076

[18] Bayraktar R,Calin GA.Cell-to-cell communication: microRNAs as hormones..Mol Oncol2017;11:1673-86 PMCID:PMC5709614

[19] Tkach M.Communication by extracellular vesicles: where we are and where we need to go..Cell2016;164:1226-32

[20] van Niel G,Raposo G.Shedding light on the cell biology of extracellular vesicles..Nat Rev Mol Cell Biol2018;19:213-28

[21] Mathieu M,Lavieu G.Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication..Nat Cell Biol2019;21:9-17

[22] Colombo M,Théry C.Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles..Annu Rev Cell Dev Biol2014;30:255-89

[23] Anfossi S,Pantel K.Clinical utility of circulating non-coding RNAs - an update..Nat Rev Clin Oncol2018;15:541-63

[24] Sung BH,Hoshino D,Weaver AM.Directional cell movement through tissues is controlled by exosome secretion..Nat Commun2015;6:7164 PMCID:PMC4435734

[25] Qu L,Chen C,Liu B.Exosome-transmitted lncARSR promotes sunitinib resistance in renal cancer by acting as a competing endogenous RNA..Cancer Cell2016;29:653-68

[26] Hoshino A,Shen TL,Hashimoto A.Tumour exosome integrins determine organotropic metastasis..Nature2015;527:329-35 PMCID:PMC4788391

[27] Costa-Silva B,Ocean AJ,Zhang H.Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver..Nat Cell Biol2015;17:816-26 PMCID:PMC5769922

[28] Peinado H,Lavotshkin S,Costa-Silva B.Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET..Nat Med2012;18:883-91 PMCID:PMC3645291

[29] Zhang HG.Exosomes: a novel pathway of local and distant intercellular communication that facilitates the growth and metastasis of neoplastic lesions..Am J Pathol2014;184:28-41 PMCID:PMC3873490

[30] Chen X,Wang X,Zhu Q.Exosomes derived from hypoxic epithelial ovarian cancer deliver microRNA-940 to induce macrophage M2 polarization..Oncol Rep2017;38:522-28

[31] Zhu L,Gangadaran P,Lee HW.Exosomes derived from natural killer cells exert therapeutic effect in melanoma..Theranostics2017;7:2732-45 PMCID:PMC5558565

[32] ussard KM,Stumpf K,Marini FC.Tumor-associated stromal cells as key contributors to the tumor microenvironment..Breast Cancer Res2016;18:84 PMCID:PMC4982339

[33] Gutkin A,Beery E,Pinchasi M.Tumor cells derived exosomes contain hTERT mRNA and transform nonmalignant fibroblasts into telomerase positive cells..Oncotarget2016;7:59173-88 PMCID:PMC5312303

[34] Zhao H,Baddour J,Bernard V.Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism..Elife2016;5:e10250 PMCID:PMC4841778

[35] Raposo G.B lymphocytes secrete antigen-presenting vesicles..J Exp Med1996;183:1161-72 PMCID:PMC2192324

[36] Zitvogel L,Lozier A,Flament C.Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes..Nat Med1998;4:594-600

[37] Jean-Philippe J,Caputi M.hnRNP A1: The Swiss Army Knife of Gene Expression..Int J Mol Sci2013;14:18999-9024 PMCID:PMC3794818

[38] Villarroya-Beltri C,Sánchez-Cabo F,Vázquez J.Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs..Nat Commun2013;4:2980 PMCID:PMC3905700

[39] Vasilescu C,Dragomir M.From mobility to crosstalk. A model of intracellular miRNAs motion may explain the RNAs interaction mechanism on the basis of target subcellular localization..Math Biosci2016;280:50-61

[40] Colombo M,van Niel G,Vigneron J.Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles..J Cell Sci2013;126:5553-65

[41] Hurley JH.ESCRTs are everywhere..EMBO J2015;34:2398-2407 PMCID:PMC4601661

[42] Guo BB,Hill AF.The Neutral Sphingomyelinase Pathway Regulates Packaging of the Prion Protein into Exosomes..J Biol Chem2015;290:3455-67 PMCID:PMC4319014

[43] van Niel G,Simoes S,Rochin L.The tetraspanin CD63 regulates ESCRT-independent and -dependent endosomal sorting during melanogenesis..Dev Cell2011;21:708-21 PMCID:PMC3199340

[44] Seabra MC,Hume AN.Rab GTPases, intracellular traffic and disease..Trends Mol Med2002;8:23-30

[45] strowski M,Krumeich S,Raposo G.Rab27a and Rab27b control different steps of the exosome secretion pathway..Nat Cell Biol2010;12:19-30

[46] ader CM,Mestre MB.TI-VAMP/VAMP7 and VAMP3/cellubrevin: two v-SNARE proteins involved in specific steps of the autophagy/multivesicular body pathways..Biochim Biophys Acta - Mol Cell Res2009;1793:1901-16

[47] ogozzi M,Angelini D,Falchi M.Microenvironmental pH and exosome levels interplay in human Cancer cell lines of different Histotypes..Cancers2018;10:370 PMCID:PMC6210604

[48] Shapiro AB.The mechanism of ATP-dependent multidrug transport by P-glycoprotein..Acta Physiol Scand Suppl1998;643:227-34

[49] Torreggiani E,Perut F,Baldini N.Multimodal transfer of MDR by exosomes in human osteosarcoma..Int J Oncol2016;49:189-96

[50] ato T,Kameyama K,Fujita Y.Serum exosomal P-glycoprotein is a potential marker to diagnose docetaxel resistance and select a taxoid for patients with prostate cancer..Urol Oncol Semin Orig Investig2015;33:385.e15-20

[51] Aung T,Vogel D,Oppermann M.Exosomal evasion of humoral immunotherapy in aggressive B-cell lymphoma modulated by ATP-binding cassette transporter A3..Proc Natl Acad Sci2011;108:15336-41 PMCID:PMC3174603

[52] Valadi H,Bossios A,Lee JJ.Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells..Nat Cell Biol2007;9:654-59

[53] Mattick JS.Non-coding RNA..Hum Mol Genet2006;15:R17-29

[54] Feeley KP.Hiding in plain sight: rediscovering the importance of noncoding RNA in human malignancy..Cancer Res2018;78:2149-58 PMCID:PMC6064611

[55] Fabbri M,Andreeff M,Garcia-Manero G.MicroRNAs and noncoding RNAs in hematological malignancies: molecular, clinical and therapeutic implications..Leukemia2008;22:1095-105

[56] Almeida MI,Zeng L,Spizzo R.Strand-specific miR-28-5p and miR-28-3p have distinct effects in colorectal cancer cells..Gastroenterology2012;142:886-96.e9 PMCID:PMC3321100

[57] Peng C.Editorial: microRNAs as new players in endocrinology..Front Endocrinol (Lausanne)2018;9:459 PMCID:PMC6107694

[58] Berindan-Neagoe I.Molecular pathways: MicroRNAs, cancer cells, and microenvironment..Clin Cancer Res2014;20:6247-53 PMCID:PMC4461223

[59] O’Brien J,Zayed Y.Overview of microRNA biogenesis, mechanisms of actions, and circulation..Front Endocrinol (Lausanne)2018;9:402 PMCID:PMC6085463

[60] Hannafon BN,Calloway CL,Lum DH.Plasma exosome microRNAs are indicative of breast cancer..Breast Cancer Res2016;18:90 PMCID:PMC5016889

[61] Figueroa J,Shahar T,Gumin J.Exosomes from glioma-associated mesenchymal stem cells increase the tumorigenicity of glioma stem-like cells via transfer of miR-1587..Cancer Res2017;77:5808-19 PMCID:PMC5668150

[62] Qin X,Zhou L,Hu Y.Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner..Int J Nanomedicine2017;12:3721-33 PMCID:PMC5439933

[63] Bach DH,Park HJ.The role of exosomes and miRNAs in drug-resistance of cancer cells..Int J Cancer2017;141:220-30

[64] Acunzo M,Wernicke D.MicroRNA and cancer - A brief overview..Adv Biol Regul2015;57:1-9

[65] Berteaux N,Monté D,Quatannens B.H19 mRNA-like noncoding RNA promotes breast cancer cell proliferation through positive control by E2F1..J Biol Chem2005;280:29625-36

[66] Bhat SA,Mumtaz PT,Dar MA.Long non-coding RNAs: mechanism of action and functional utility..Non-coding RNA Res2016;1:43-50 PMCID:PMC6096411

[67] Wang KC.Molecular mechanisms of long noncoding RNAs..Mol Cell2011;43:904-14 PMCID:PMC3199020

[68] Shah MY,Pileczki V,Redis R.Cancer-associated rs6983267 SNP and its accompanying long noncoding RNA CCAT2 induce myeloid malignancies via unique SNP-specific RNA mutations..Genome Res2018;28:432-47 PMCID:PMC5880235

[69] Rigoutsos I,Nam SY,Pasculli B.N-BLR, a primate-specific non-coding transcript leads to colorectal cancer invasion and migration..Genome Biol2017;18:98 PMCID:PMC5442648

[70] Brown CJ,Powers VE,Ballabio A.Localization of the X inactivation centre on the human X chromosome in Xq13..Nature1991;349:82-4

[71] Long Y,Youmans DT.How do lncRNAs regulate transcription?.Sci Adv2017;3:eaao2110 PMCID:PMC5617379

[72] Bi H,Yuan J,Xu D.H19 inhibits RNA polymerase II-mediated transcription by disrupting the hnRNP U-actin complex..Biochim Biophys Acta - Gen Subj2013;1830:4899-906

[73] Salmena L,Tay Y,Pandolfi PP.A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?.Cell2011;146:353-8 PMCID:PMC3235919

[74] Shan Y,Pan Y,Liu B.LncRNA SNHG7 sponges miR-216b to promote proliferation and liver metastasis of colorectal cancer through upregulating GALNT1..Cell Death Dis2018;9:722 PMCID:PMC6006356

[75] Chen F,Tan HY,Zhang C.The functional roles of exosomes-derived long non-coding RNA in human cancer..Cancer Biol Ther2019;20:583-92 PMCID:PMC6605993

[76] Wu D,Beretov J,Willcox M.Urinary biomarkers in prostate cancer detection and monitoring progression..Crit Rev Oncol Hematol2017;118:15-26

[77] Hessels D,van Oort I,van Leenders GJL.DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer..Eur Urol2003;44:8-16

[78] Jiang N,Fang S,Han Y.Liquid biopsy: circulating exosomal long noncoding RNAs in cancer..Clin Chim Acta2019;495:331-7

[79] Zhang R,Wang Z,Chen Y.Serum long non coding RNA MALAT-1 protected by exosomes is up-regulated and promotes cell proliferation and migration in non-small cell lung cancer..Biochem Biophys Res Commun2017;490:406-14

[80] Li C,Shao C,Zhang T.Tumor-derived exosomal lncRNA GAS5 as a biomarker for early-stage non-small-cell lung cancer diagnosis..J Cell Physiol2019;234:20721-7

[81] Teng Y,Chu Y.Identification of an Exosomal Long Noncoding RNA SOX2-OT in Plasma as a Promising Biomarker for Lung Squamous Cell Carcinoma..Genet Test Mol Biomarkers2019;23:235-40

[82] Lang HL,Chen Y,Tu W.Glioma cells promote angiogenesis through the release of exosomes containing long non-coding RNA POU3F3..Eur Rev Med Pharmacol Sci2017;21:959-72

[83] Li Z,Li J,Zhao X.Tumor-derived exosomal lnc-Sox2ot promotes EMT and stemness by acting as a ceRNA in pancreatic ductal adenocarcinoma..Oncogene2018;37:3822-38

[84] Hardin H,Meyer K,Zhang R.Thyroid cancer stem-like cell exosomes: regulation of EMT via transfer of lncRNAs..Lab Investig2018;98:1133-42 PMCID:PMC6138523

[85] Li X,Wu M.Regulation of macrophage activation and polarization by HCC-derived exosomal lncRNA TUC339..Int J Mol Sci2018;19: PMCID:PMC6213212

[86] Pérez-Herrero E.Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy..Eur J Pharm Biopharm2015;93:52-79

[87] Zhang Z,Lu C,Zeng A.Exosomal transfer of long non-coding RNA SBF2-AS1 enhances chemoresistance to temozolomide in glioblastoma..J Exp Clin Cancer Res2019;38:166 PMCID:PMC6469146

[88] Takahashi K,Wood J,Patel T.Involvement of extracellular vesicle long noncoding RNA (linc-VLDLR) in tumor cell responses to chemotherapy..Mol Cancer Res2014;12:1377-87 PMCID:PMC4201956

[89] Takahashi K,Kogure T,Patel T.Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer..FEBS Open Bio2014;4:458-67 PMCID:PMC4050189

[90] Dong H,Chen R,Zou K.Exosome-mediated transfer of lncRNA-SNHG14 promotes trastuzumab chemoresistance in breast cancer..Int J Oncol2018;53:1013-26

[91] Yang Y,Du J,Li Y.Predictive role of UCA1-containing exosomes in cetuximab-resistant colorectal cancer..Cancer Cell Int2018;18:164 PMCID:PMC6196422

[92] Kang M,Li Y,Deng M.Exosome-mediated transfer of lncRNA PART1 induces gefitinib resistance in esophageal squamous cell carcinoma via functioning as a competing endogenous RNA..J Exp Clin Cancer Res2018;37:171 PMCID:PMC6063009

[93] Lei Y,Chen B,Gong J.Tumor-released lncRNA H19 promotes gefitinib resistance via packaging into exosomes in non-small cell lung cancer..Oncol Rep2018;40:3438-46

[94] Zhang W,Yu J,Qian Q.Exosome-mediated transfer of lncRNA RP11-838N2.4 promotes erlotinib resistance in non-small cell lung cancer..Int J Oncol2018;53:527-38 PMCID:PMC6017264

[95] Dunnwald LK,Li CI.Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients..Breast Cancer Res2007;9:R6 PMCID:PMC1851385

[96] Gomez-Fernandez C,Nassiri M,Alvarez C.Immunohistochemically determined estrogen receptor phenotype remains stable in recurrent and metastatic breast cancer..Am J Clin Pathol2008;130:879-82

[97] Harbeck N.Breast cancer..Lancet2017;389:1134-50

[98] Shagufta Ahmad I.Tamoxifen a pioneering drug: an update on the therapeutic potential of tamoxifen derivatives..Eur J Med Chem2018;143:515-31

[99] Xu CG,Ren YQ,Wang LQ.Exosomes mediated transfer of lncRNA UCA1 results in increased tamoxifen resistance in breast cancer cells..Eur Rev Med Pharmacol Sci2016;20:4362-8

[100] Abril-Rodriguez G.SnapShot: immune checkpoint inhibitors..Cancer Cell2017;31:848-848.e1

[101] Jaafar J,Alwan H.Programmed cell death-1 and programmed cell death ligand-1 antibodies-induced dysthyroidism..Endocr Connect2018;7:R196-211 PMCID:PMC5937198

[102] Nanda R,Dees EC,Gupta S.Pembrolizumab in patients with advanced triple-negative breast cancer: phase Ib KEYNOTE-012 study..J Clin Oncol2016;34:2460-7

[103] Hu Q,Chan LC,Liang K.Oncogenic lncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppression..Nat Immunol2019;20:835-51 PMCID:PMC6619502